These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19482606)
21. [Conformationally altered proteins cause neurodegenerative diseases]. Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392 [TBL] [Abstract][Full Text] [Related]
22. The "Jekyll and Hyde" Actions of Nucleic Acids on the Prion-like Aggregation of Proteins. Silva JL; Cordeiro Y J Biol Chem; 2016 Jul; 291(30):15482-90. PubMed ID: 27288413 [TBL] [Abstract][Full Text] [Related]
23. Structural Fuzziness of the RNA-Organizing Protein SERF Determines a Toxic Gain-of-interaction. Meyer NH; Dellago H; Tam-Amersdorfer C; Merle DA; Parlato R; Gesslbauer B; Almer J; Gschwandtner M; Leon A; Franzmann TM; Grillari J; Kungl AJ; Zangger K; Falsone SF J Mol Biol; 2020 Feb; 432(4):930-951. PubMed ID: 31794729 [TBL] [Abstract][Full Text] [Related]
24. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration? Yan X; Uronen RL; Huttunen HJ Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880 [TBL] [Abstract][Full Text] [Related]
25. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases. Legname G; Scialò C Prion; 2020 Dec; 14(1):257-270. PubMed ID: 33345731 [TBL] [Abstract][Full Text] [Related]
26. Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins. Silva JL; Vieira TC; Gomes MP; Bom AP; Lima LM; Freitas MS; Ishimaru D; Cordeiro Y; Foguel D Acc Chem Res; 2010 Feb; 43(2):271-9. PubMed ID: 19817406 [TBL] [Abstract][Full Text] [Related]
28. Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins. Hong L; Simon JD Metallomics; 2011 Mar; 3(3):262-6. PubMed ID: 21116546 [TBL] [Abstract][Full Text] [Related]
29. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. Uversky VN J Biomol Struct Dyn; 2003 Oct; 21(2):211-34. PubMed ID: 12956606 [TBL] [Abstract][Full Text] [Related]
30. Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases. Victoria GS; Zurzolo C Virus Res; 2015 Sep; 207():146-54. PubMed ID: 25645281 [TBL] [Abstract][Full Text] [Related]
31. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects]. Tarutani A; Hisanaga SI; Hasegawa M Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107 [TBL] [Abstract][Full Text] [Related]
32. Dependence of alpha-synuclein aggregate morphology on solution conditions. Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698 [TBL] [Abstract][Full Text] [Related]
34. Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations. Dasari AKR; Kayed R; Wi S; Lim KH Biochemistry; 2019 Jun; 58(25):2814-2821. PubMed ID: 31132261 [TBL] [Abstract][Full Text] [Related]
35. Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer. Cordeiro Y; Foguel D; Silva JL Biophys Chem; 2013 Dec; 183():9-18. PubMed ID: 23849959 [TBL] [Abstract][Full Text] [Related]
36. Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders. Wang Y; Meriin AB; Costello CE; Sherman MY Prion; 2007; 1(2):128-35. PubMed ID: 19164926 [TBL] [Abstract][Full Text] [Related]
37. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652 [TBL] [Abstract][Full Text] [Related]
38. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis]. Yoshida K; Higuchi K; Ikeda S Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474 [TBL] [Abstract][Full Text] [Related]
39. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802 [TBL] [Abstract][Full Text] [Related]
40. Prion-like spread of protein aggregates in neurodegeneration. Polymenidou M; Cleveland DW J Exp Med; 2012 May; 209(5):889-93. PubMed ID: 22566400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]